Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-30T19:04:21.320Z Has data issue: false hasContentIssue false

Ethical Aspects of Patenting Inventions Involving Elements of Human Origin: Group of Advisers on the Ethical Implications of Biotechnology

Published online by Cambridge University Press:  17 May 2016

Get access

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Report to the European Commission
Copyright
Copyright © Association for Politics and the Life Sciences 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Notes

1. Professor Dietmar Mieth adopts the present opinion but considers that the point 2.5 be completed with the following text:Google Scholar

A patent can be granted on an innovation capable of industrial application, which relates to an element of human origin, like an isolated gene, if this element has been essentially changed. It is not essentially changed if the structure of the element is identical to an element (gene) to be found in the human body or if the genetic information is identical to the information of a human gene inside the human body. The granting of a patent is justified for an innovation that shows a new therapeutic application or use of a gene or a partial sequence of an even unchanged gene. In these cases—patent on process and patent on product—the need to encourage European research and the use of its results may outweigh other aspects. The patent must not cover the gene itself, but the specific identified use of the gene.Google Scholar